Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing product development New tagline to emphasize the company’s ...

Scientists at Nanyang Technological University, Singapore (NTU Singapore), have made a crucial breakthrough by successfully ...

Made by combining several emerging technologies, human “bodyoids” could reduce animal testing, improve drug development, and alleviate organ shortages.

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

Human aging significantly contributes to cognitive decline and increased susceptibility to late-life neurodegenerative diseases (e.g.Alzheimer’ s disease, ...

A novel regimen significantly reduced risk for moderate to severe chronic graft-versus-host disease for certain patients who ...

A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal cord injury. The ...

The Mayo Clinic Center for Regenerative Biotherapeutics manufactures a wide range of products for active, early-phase clinical trials.

A growing body of work suggests that cell metabolism — the chemical reactions that provide energy and building materials — ...

Although cystic fibrosis is a single gene mutation, there are more than 1,000 different ways the CFTR gene can mutate in ...

Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...